PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2009 | 53 | 1 |

Tytuł artykułu

Effects of aflatoxin B1, ochratoxin A, patulin, citrinin, and zearalenone on the in vitro proliferation of pig blood lymphocytes

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The effects of aflatoxin B₁ (AFB₁), ochratoxin A (OTA), patulin (PAT), citrinin (CIT), and zearalenone (ZEA) on in vitro response of pig peripheral blood mononuclear cells to mitogen concanavalin A was assayed after three days of incubation using ³H- thymidine uptake. Dose response curves for each mycotoxin were generated and the concentrations producing 50% inhibition of cell proliferation (IC₅₀) were estimated. AFB₁, OTA, and PAT were the most potent toxins with the IC₅₀ of 0.06, 0.17, and 0.19 µmol/L, respectively (0.2, 0.7, and 0.3 µg/mL, respectively). Based on the molar concentration, the inhibition potencies relative to that of AFB₁ were determined. OTA had 35% and PAT 31% potency to that of AFB₁, but CIT and ZEA had only 1.6 and 1.9 of AFB₁ inhibition potencies.

Wydawca

-

Rocznik

Tom

53

Numer

1

Opis fizyczny

p.129-134,fig.,ref.

Twórcy

autor
  • National Veterinary Research Institute, 24-100 Pulawy, Poland
autor
autor
autor

Bibliografia

  • 1. Baerstchi S.S., Raney K.D., Stone M.P., Harris T.M.: Preparation of the 8,9 epoxide of the mycotoxin aflatoxin B₁ the ultimate carcinogen. J Am Chem Soc 1988, 110, 7929-7931.
  • 2. Bennett J.W., Klich M.: Mycotoxins. Clin Microbiol Rev 2003, 16, 497-516.
  • 3. Berek L., Petri I.B., Mesterhazy A., Teren J., Mohnar J.: Effects of mycotoxins on human immune functions in vitro. Toxicol In Vitro 2001, 15, 25-33.
  • 4. Bing-Hui L., Feng-Yih Y., Ming-Huan C., Yi-Ling Y.: The effects of mycotoxins, fumonisin B, and aflatoxin B₁ on primary swine macrophages. J Appl Pharmacol 2002, 180, 197-204.
  • 5. Bondy G.S., Pestka J.J.: Immunomodulation by fungal toxins. J Toxicol Environ Health B; Crit Rev 2000, 3, 73- 87.
  • 6. Bretta B., Giaschi A., Galii C.L., Restani P.: Patulin in apple based foods: occurrence and safety evaluation. Food Addit Contam 2000, 17, 399-406.
  • 7. Burns-Naas L.A., Meade B.J., Munson A.E.: Toxic response of the immune system. In: Cassarett and Doull's Toxicology. Edited by Klaassen C.D., ed. McGraw-Hill, New York, 2001, pp. 419-470.
  • 8. Clark H.A., Snedeker S.M.: Ochratoxin A: its cancer risk and potential for exposure. J Toxicol Environ Health B; Crit Rev 2006, 9, 265-296.
  • 9. Colosio C., Corsini E., Barcellini W., Maroni W.: Immune parameters in biological monitoring of pesticide exposure: current knowledge and perspective. Toxicol Lett 1999, 108, 285-395.
  • 10. Cooray R.: Effect of some mycotoxins on mitogen induced blastogenesis and SCE frequency in human lymphocytes. Food Chem Toxicol 1984, 22, 529-534.
  • 11. Dailey R.E., Blaschka A.M., Brouver E.A.: Absorption, distribution, extraction of [14C]-patulin by rats. J Toxicol Environ Health 1977, 3, 479-489.
  • 12. Eaton D.L., Gallagher E.P.: Mechanism of aflatoxin carcinogenesis. Ann Rev Pharmacol Toxicol 1994, 34, 153-157.
  • 13. Escoula L., Thomsen M., Bourdiol D., Pipy B., Peuriere S., Roubinet F.: Patuline immunotoxicology: effect on phagocyte activation and the cellular and humoral immune system of mice and rabbits. Int J Immunopharmacol 1988, 10, 983-989.
  • 14. Hamed S., Foster J.S., Bukowsky A., Wimalasena J.: Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell- cycle progression in MCF-7 cells. Mol Carcinog 2001, 30, 88-98.
  • 15. Holmberg T., Thuvanier A., Hult K.: Ochratoxin A as suppressor of mitogen induced blastogenesis of porcine blood lymphocytes. Acta Vet Scand 1988, 29, 219-223.
  • 16. Hussein H.S., Brasel J.M.: Toxicity, metabolism, and impact on humans and animals. Toxicology 2001, 167, 101-134.
  • 17. Keblys M., Bernhoft A., Hoffer C., Morrison E., Jorgen S., Flaoyen L., Flaoyen M.: The effect of the Penicillium mycotoxins, citrinin, cyclopiazonic acid, ochratoxin A, patulin, penicillic acid, and roqueforteine C on in vitro proliferation of porcine lymphocytes. Mycopathologia 2004, 158, 317-324.
  • 18. Khalili B., Montanaro M.T., Bardana E.J.: Inhaiational mold toxicity: fact or fiction? A clinical review of 50 cases. Ann Allergy Asthma Immunol 2005, 95, 239-246.
  • 19. Kristensen F., Kristensen B., Lazary S.: The lymphocyte stimulation test in veterinary immunology. Vet Immunol Immunopathol 1982, 3, 203-207.
  • 20. Langseth W., Nymoen U., Bergsjo B.: Ochratoxin A in plasma of Norwegian swine determined by an HPLC column-switching method. Nat Toxins 1993, 1, 216-221.
  • 21. Lewellyn G.C., McCay J.A., Brown F.D., Musgrowe D.L., Butterwods L.F., Munson A.E., White K.L.: Immunological evaluation of the mycotoxin patulinin in female in B6C3F mice. Food Chem Toxicol 1998, 36, 1107-1115.
  • 22. Lioi M.B., Santoro A., Barbieri R., Salzano S., Ursini M.V.: Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutation Res 2004, 557, 19-27.
  • 23. Marin M.L., Murcha J., Dong W., Pestka J.J.: Effects of mycotoxins on cytokine production and proliferation in EL-thymoma cells. J Toxicol Environ Health 1996, 48, 379-396.
  • 24. Minervini F., Dell' Aquila M.E., Maritato F., Minoia P., Visconti A.: Toxic effects of the mycotoxin zearalenone and its derivatives on the in vitro maturation of bovine oocytes and 17ß-estradiol levels in mural granulosa cell cultures. Toxicol In Vitro 2001, 15, 485-495.
  • 25. Olsen J.H., Dragsted I., Autrup H.: Cancer risk and occupational exposure to aflatoxin in Denmark. R J Cancer 1988, 58, 392-396.
  • 26. Ominski K.H., Frohlich A.A., Marquardt R.R., Crow G.H., Abranson D.: The incidence and distribution of ochratoxin A in Western Canadian swine. Food Addit Contam 1996, 13, 185-198.
  • 27. Peterson T.C.: Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation. Biochem Pharmacol 1987, 36, 3911-3916.
  • 28. Fohl-Leszkowicz A., Petkowa-Bocharowa T., Chernozer I.N., Castegnaro M.: Balkan endemic nephropathy and associated urinary tract tumours: review on aetiological causes and the potential role of mycotoxins. Food Add Cont 2002, 19, 282-302.
  • 29. Sandor G., Busch A., Watzke H., Reek J., Vanyi A.: Subacute toxicity testing of ochratoxin A and citrinin in swine. Acta Vet Hung 1991, 39, 149-160.
  • 30. Speijers G.J.A., Speijers M.H.M.: Combined toxic effects. Toxicol Lett 2004, 153, 91-98.
  • 31. Stec J.: Effect of cadmium and lead on ³H-thymidine uptake in sheep lymphocytes infected with bovine leukaemia virus. Bull Vet Inst Pulawy 2003, 47, 77-87.
  • 32. Stec J., Szczotka M., Kuźmak J.: Cytotoxicity of feed- borne mycotoxins to animal cell lines in vitro using the MTT assay. Bull Vet Inst Pulawy 2007, 51, 679-684.
  • 33. Stec J., Rachubik J., Szczotka M., Kuźmak J.: The effects of the Penicillium mycotoxins: citrinin, ochratoxin A, and patulin on in vitro proliferation of bovine lymphocytes. Bull Vet Inst Pulawy 2008, 52, 163-167.
  • 34. Stoev S.D., Hald B., Mantle P.G.: Porcine nephropathy in Bulgaria: a progressive syndrome of complex or uncertain (mycotoxin) aetiology. Vet Rec 1998, 142, 190-194.
  • 35. Tammer B., Lehmann I., Nieber K., Altenburger R.: Combined effects of mycotoxin mixture on human T cell function. Toxicol Lett 2007, 150, 124-133.
  • 36. Theumer M.G., Lopez A.G., Masih D.T., Chulze S.N., Rubinstein H.R.: Immunobological effects of AFB₁ and AFB₁-FB₁ mixture in experimental subchronic mycotoxicoses in rats. Toxicology 2003, 186, 159-170.
  • 37. Wichmann G., Herbarth O., Lehmann I.: The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol 2002, 17, 211-218.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-63ea881b-f7bb-44de-a5db-a280b319730c
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.